Wednesday, May 2, 2018

Blood Cancer Journal - Table of Contents alert Volume 8 April 2018

If you are unable to see the message below, click here to view.
Blood Cancer Journal
TABLE OF CONTENTS

Volume 8 (April 2018)

In this issue
Correspondence
Article
 
Advertisement
Nature Outlook: Cancer immunotherapy

Drugs that mobilize our immune systems against cancer are dramatically improving care for many people, and research is rapidly moving ahead in the lab and the clinic. 

Access this Outlook free >>

Produced with support from: 
F. Hoffmann-La Roche Ltd  
Medimmune 
Produced with support of a grant from Merck & Co., Inc.
 

Correspondence

 

Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome

Hao Zhao, Hao Cai, Chen Wang, Xu-fei Huang, Xin-xin Cao et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0073-8

Abstract | Full Text

DNMT3AR882-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3AR882C OCI-AML3 leukemia cell line

David Chen, Matthew Christopher, Nichole M. Helton, Ian Ferguson, Timothy J. Ley et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0072-9

Abstract | Full Text

Article

 

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Hsin-An Hou, Cheng-Hong Tsai, Chien-Chin Lin, Wen-Chien Chou, Yuan-Yeh Kuo et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0074-7

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: